CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $89,000 | +7.2% | 750 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $83,000 | +7.8% | 750 | 0.0% | 0.01% | +16.7% |
| Q2 2020 | $77,000 | -4.9% | 750 | 0.0% | 0.01% | -14.3% |
| Q1 2020 | $81,000 | -6.9% | 750 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $87,000 | +1.2% | 750 | 0.0% | 0.01% | -12.5% |
| Q3 2019 | $86,000 | +21.1% | 750 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $71,000 | +4.4% | 750 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $68,000 | +19.3% | 750 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $57,000 | -36.7% | 750 | -17.6% | 0.01% | -33.3% |
| Q2 2018 | $90,000 | +21.6% | 910 | 0.0% | 0.01% | +20.0% |
| Q1 2018 | $74,000 | +2.8% | 910 | 0.0% | 0.01% | -9.1% |
| Q4 2017 | $72,000 | – | 910 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kite Lake Capital Management (UK) LLP | 207,382 | $24,135,000 | 76.46% |
| Maso Capital Partners Ltd | 539,597 | $62,798,000 | 20.20% |
| York Capital Management Global Advisors, LLC | 1,102,163 | $128,270,000 | 7.40% |
| HHLR ADVISORS, LTD. | 2,751,200 | $320,185,000 | 3.99% |
| Dalton Investments, Inc. | 15,551 | $1,810,000 | 1.14% |
| Athos Capital Ltd | 8,290 | $965,000 | 0.96% |
| Myriad Asset Management Ltd. | 67,019 | $7,799,000 | 0.94% |
| Temasek Holdings (Private) Ltd | 990,000 | $115,216,000 | 0.75% |
| OXFORD ASSET MANAGEMENT LLP | 211,646 | $24,631,000 | 0.68% |
| AGF Investments America Inc. | 12,230 | $1,423,000 | 0.47% |